In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a
number of issues associated with conventional therapeutic agents, including their poor …

Nanoparticles possess enormous potential as diagnostic imaging agents and hold promise
for the development of multimodality agents with both imaging and therapeutic capabilities …

The development of tumor-targeted therapies using monoclonal antibodies has been
successful during the last 30 years. Nevertheless, the efficacy of antibody-based therapy is …

With the arrival of antibiotics 70 years ago, meant a paradigm shift in overcoming infectious
diseases. For decades, drugs have been used to treat different infections. However, with …

The development of long‐term human organotypic liver‐on‐a‐chip models for successful
prediction of toxic response is one of the most important and urgent goals of the …

Autoantibodies against autologus tumor‐associated antigens have been detected in the
asymptomatic stage of cancer and can thus serve as biomarkers for early cancer diagnosis …

Liver cirrhosis is frequently accompanied by disease-related malnutrition (DRM) and
sarcopenia, defined as loss of skeletal muscle mass and function. DRM and sarcopenia …

Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the complex metabolic
derangements associated with obesity. NAFLD is characterized by excessive deposition of …

Холестаз представляет собой нарушение синтеза, секреции и оттока желчи.
Клинические признаки заболевания—слабость, кожный зуд и в ряде случаев желтуха …

Background The presence and progression of hepatic (liver) fibrosis into cirrhosis is a
prognostic variable having impact on survival in people with alcoholic liver disease. Liver …